Skip to main navigation Skip to search Skip to main content

Re: Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19'' by Sengupta et al.

  • Agency for Science, Technology and Research, Singapore
  • University of Duisburg-Essen
  • University of Vermont
  • Johns Hopkins University
  • Innsbruck Medical University
  • Paracelsus Private Medical University
  • Research and Transfer Center for Extracellular Vesicle Theralytic Technologies in Salzburg (EV-TT)

Research output: Contribution to journalLetterpeer-review

23 Scopus citations
Original languageEnglish
Pages (from-to)877-878
Number of pages2
JournalStem Cells and Development
Volume29
Issue number14
DOIs
StatePublished - Jul 2020
Externally publishedYes

Cite this